Covidien Ltd. (NYSE:COV)

CAPS Rating: 4 out of 5

The Company is in the business of developing, manufacturing and distributing medical devices and supplies, diagnostic imaging agents, pharmaceuticals and other healthcare products for use in clinical and home settings.


Player Avatar BrentonKJ (25.92) Submitted: 10/13/2012 2:28:14 PM : Outperform Start Price: $53.04 COV Score: +21.14

Great management. Good PE and solid dividend. Investing heavily in R and D.

Featured Broker Partners